Delivery Order SPE2DR25D1103-SPE2DR26FE153
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,180.40 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on December 8, 2025, with completion scheduled for December 9, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency awarded a $5,579.73 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to the vendor's corporate headquarters...
- The Defense Logistics Agency awarded a $3,118.79 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at the vendor's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens with a ceiling value of $4,035.46. This is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,298.53 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $5,317.77 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999 and extends through December 2026. The product will be delivered to AmerisourceBergen's location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $1,993.08. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $10,700.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Trulicity 3 mg/0.5 mL pens (0.5 mL). Performance will be completed by September 15, 2025, with fulfillment from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $1,380.90 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 26, 2025, with completion expected by August 27, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and specifies performance at the vendor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a ceiling value of $17,924.61. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The order is scheduled for completion by November 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE153Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a ceiling value of $2,180.40. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement and is due for completion by December 3, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's role as a prime vendor through the DLA Troop Support Medical IDC enables it to supply a comprehensive range of pharmaceutical products and medical supplies globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for Trulicity, a diabetes medication, exemplifies the company's ongoing provision of essential pharmaceutical commodities to support Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/1/25 |